您好，欢迎来到易推广！ 请登录 免费注册

上海陶术生物科技有限公司 主营产品：生物试剂,实验服务等

当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示

企业档案

会员类型：会员

已获得易推广信誉   等级评定
139成长值

(0 -40)基础信誉积累，可浏览访问

(41-90)良好信誉积累，可接洽商谈

(91+  )优质信誉积累，可持续信赖

易推广会员：5年

工商认证 【已认证】

最后认证时间：

注册号： 【已认证】

法人代表： 【已认证】

企业类型：生产商 【已认证】

注册资金：人民币万 【已认证】

产品数：86101

参观次数：3863260

手机网站：http://m.yituig.com/c135739/

旗舰版地址：http://tsbiochem.app17.com

自主品牌

自主品牌

已选条件

  • T62687Drp1-IN-1；化合物 Drp1-IN-1Drp1-IN-1

    Drp1-IN-1 (comp A-7) is a Drp1 protein inhibitor (IC50: 0.91 μM).

    价 格：￥电议型 号：T62687产 地：中国大陆

  • T62682FGFR4-IN-10；化合物 FGFR4-IN-10FGFR4-IN-10

    FGFR4-IN-10 (compound 5a) is a selective and potent inhibitor of FGFR4 (IC50: 70.7 nM).FGFR4-IN-10 does not inhibit other FGFR family members (i.e., FGFR1, FGFR2, and FGFR3).

    价 格：￥电议型 号：T62682产 地：中国大陆

  • T62679LSD1-IN-13 hydrochloride；化合物 LSD1-IN-13 hydrochlorideLSD1-IN-13 hydrochloride

    LSD1-IN-13 hydrochloride (compound 7e) is an orally active inhibitor of LSD1 (IC50: 24.43 nM). hydrochloride induces differentiation of AML (acute myeloid leukemia) cell lines.

    价 格：￥电议型 号：T62679产 地：中国大陆

  • T62668CDK2-IN-12；化合物 CDK2-IN-12CDK2-IN-12

    CDK2-IN-12 (compound 10b) is a potent inhibitor of CDK2 (IC50: 11.6 μM). CDK2-IN-12 exhibits inhibition of hCA subtypes I, II, IX and XII with KI values of 3534, 638.4, 44.3 and 48.8 nM, respectively. CDK2-IN-12 shows CDK2-IN-12 showed anti-cancer effects.

    价 格：￥电议型 号：T62668产 地：中国大陆

  • T62651ATR-IN-11；化合物 ATR-IN-11ATR-IN-11

    ATR-IN-11 (Compound Hit01) is a potent inhibitor of ataxia capillaris and Rad3-related (ATR) kinases. ATR-IN-11 is a promising lead compound for the discovery of subsequent drugs targeting the ATR kinase, a key regulatory protein in the DNA damage response (DDR) responsible for sensing replication stress (RS). ATR-IN-11 has potential for cancer disease research.

    价 格：￥电议型 号：T62651产 地：中国大陆

  • T62648DNA-PK-IN-1；化合物 DNA-PK-IN-1DNA-PK-IN-1

    DNA-PK-IN-1 is a potent inhibitor of DNA-PK. DNA-PK-IN-1 has potential for cancer disease research.

    价 格：￥电议型 号：T62648产 地：中国大陆

  • T62645HPK1-IN-14；化合物 HPK1-IN-14HPK1-IN-14

    HPK1-IN-14 is a potent inhibitor of HPK1. HPK1-IN-14 has potential for the study of HPK1-related diseases.

    价 格：￥电议型 号：T62645产 地：中国大陆

  • T62638IDO1-IN-18；化合物 IDO1-IN-18IDO1-IN-18

    IDO1-IN-18 (Compound 14) is a potent inhibitor of IDO1. IDO1-IN-18 has potential for cancer disease research.

    价 格：￥电议型 号：T62638产 地：中国大陆

  • T62636MsbA-IN-1；化合物 MsbA-IN-1MsbA-IN-1

    MsbA-IN-1 is a potent inhibitor of MsbA (IC50: 4 nM). MsbA-IN-1 has anti-E. coli activity (MIC: 79 μM). MsbA-IN-1 fully penetrates the outer membrane of Gram-negative bacteria and exhibits inhibition of MsbA.

    价 格：￥电议型 号：T62636产 地：中国大陆

  • T62629HPK1-IN-13；化合物 HPK1-IN-13HPK1-IN-13

    HPK1-IN-13 is a potent inhibitor of HPK1. HPK1-IN-12 has potential for the study of HPK1-related diseases.

    价 格：￥电议型 号：T62629产 地：中国大陆

  • T62628HPK1-IN-12；化合物 HPK1-IN-12HPK1-IN-12

    HPK1-IN-12 is a potent inhibitor of HPK1. HPK1-IN-12 has potential for the study of HPK1-related diseases.

    价 格：￥电议型 号：T62628产 地：中国大陆

  • T62626HBV-IN-12；化合物 HBV-IN-12HBV-IN-12

    HBV-IN-12 is a potent inhibitor of hepatitis B surface antigen (HBsAg) (0.001 μM < EC50 ≤ 0.05 μM). HBV-IN-12 is anti-HBV DNA (0.001 μM < EC50 ≤ 0.02 μM).

    价 格：￥电议型 号：T62626产 地：中国大陆

  • T62624LpxA-IN-1；化合物 LpxA-IN-1LpxA-IN-1

    LpxA-IN-1, a novel UDP-N-acetylglucosamine acyltransferase (LpxA) inhibitor exhibiting potent activity (IC 50 2 nM), effectively targets Pseudomonas aeruginosa with a minimum inhibitory concentration (MIC) of 8 μg/mL.

    价 格：￥电议型 号：T62624产 地：中国大陆

  • T62607FLT3-IN-15；化合物 FLT3-IN-15FLT3-IN-15

    FLT3-IN-15 is an orally active and potent FLT3 inhibitor, capable of acting on FLT3 (IC50: 0.87 nM) and FLT3/D835Y (IC50: 0.32 nM).

    价 格：￥电议型 号：T62607产 地：中国大陆

  • T62605CDK4/6-IN-13；化合物 CDK4/6-IN-13CDK4/6-IN-13

    Compounds 10B and 10C, functioning as cdk4/6 inhibitors, demonstrated low nanomolar activity, optimal antiproliferative effects, excellent metabolic properties, and acceptable pharmacokinetics targeting cdk4/6.

    价 格：￥电议型 号：T62605产 地：中国大陆

  • T62579HBV-IN-19；化合物 HBV-IN-19HBV-IN-19

    HBV-IN19 has inhibitory effects on hepatitis B virus (HBV) infection. HBV-IN19 inhibits HBsAg secretion and/or production and can be used in the study of HBV infection (e.g. chronic HBV infection).

    价 格：￥电议型 号：T62579产 地：中国大陆

  • T62578BuChE-IN-1；化合物 BuChE-IN-1BuChE-IN-1

    BuChE-IN-1 (Compound 23) is a potent, highly blood-brain barrier-permeable, low cytotoxicity inhibitor of butyrylcholinesterase (BuChE). BuChE-IN-1 is a BuChE inhibitor that has the potential to be used in the study of AD.

    价 格：￥电议型 号：T62578产 地：中国大陆

  • T62563ATR-IN-12；化合物 ATR-IN-12ATR-IN-12

    ATR-IN-12 (Compound 5g) is a potent inhibitor of ataxia capillaris and Rad3-related (ATR) kinase (IC50: 0.007 μM). ATR-IN-12 is a promising lead compound for subsequent drug discovery studies on ATR kinases.

    价 格：￥电议型 号：T62563产 地：中国大陆

  • T62561TRK-IN-17；化合物 TRK-IN-17TRK-IN-17

    TRK-IN-17 is a potent inhibitor of TRK. Among them is promyosin-related kinase (Trks), a member of the receptor tyrosine kinase family, which is activated by neurotrophic factors. Neurotrophic factors are a group of soluble growth factors including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and neurotrophic factor-3 (NT-3), and neurotrophic factor-4/5 (NT-4/5).TRK-IN-17 has potential for cancer disease research.

    价 格：￥电议型 号：T62561产 地：中国大陆

  • T62557CSF1R-IN-14；化合物 CSF1R-IN-14CSF1R-IN-14

    CSF1R-IN-14, an isoindolinone derivative compound, is a potent inhibitor of CSF1R. CSF1R-IN-14 has potential for cancer disease research.

    价 格：￥电议型 号：T62557产 地：中国大陆

155565758596061626364101下一页共101页

展台首页| 公司简介| 供应产品| 产品目录| 公司动态| 荣誉证书| 招聘信息| 技术中心| 联系我们| 会员管理

易推广  设计制作，未经允许翻录必究.Copyright(C) 2009 http://www.yituig.com, All rights reserved.

以上信息由企业自行提供，信息内容的真实性、准确性和合法性由相关企业负责，易推广对此不承担任何责任.   总访问量：3863260

中国彩虹热线

快速导航

返回顶部
在线咨询

提交